申请人:Incyte Corporation
                            
                            
                                公开号:US11401279B2
                            
                            
                                公开(公告)日:2022-08-02
                            
                            
The present disclosure is directed to compounds of Formula (I):
which modulate PD-1/PD-L1 protein/protein interaction, compositions, and methods of treating various diseases, including infectious diseases and cancer.
                            本公开涉及式 (I) 化合物:
调节 PD-1/PD-L1 蛋白/蛋白相互作用的化合物、组合物以及治疗各种疾病(包括传染性疾病和癌症)的方法。